Mind Medicine (MindMed) Statistics
Total Valuation
MNMD has a market cap or net worth of $620.41 million. The enterprise value is $382.27 million.
| Market Cap | 620.41M |
| Enterprise Value | 382.27M |
Important Dates
The last earnings date was Wednesday, May 8, 2024, after market close.
| Earnings Date | May 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MNMD has 70.50 million shares outstanding. The number of shares has increased by 25.69% in one year.
| Shares Outstanding | 70.50M |
| Shares Change (YoY) | +25.69% |
| Shares Change (QoQ) | +18.95% |
| Owned by Insiders (%) | 2.67% |
| Owned by Institutions (%) | 49.12% |
| Float | 57.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.16 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.91, with a Debt / Equity ratio of 0.07.
| Current Ratio | 3.91 |
| Quick Ratio | n/a |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -287.75 |
Financial Efficiency
Return on equity (ROE) is -105.30% and return on invested capital (ROIC) is -45.28%.
| Return on Equity (ROE) | -105.30% |
| Return on Assets (ROA) | -73.30% |
| Return on Capital (ROIC) | -45.28% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.20M |
| Employee Count | 57 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +148.59% in the last 52 weeks. The beta is 2.48, so MNMD's price volatility has been higher than the market average.
| Beta (1Y) | 2.48 |
| 52-Week Price Change | +148.59% |
| 50-Day Moving Average | 9.33 |
| 200-Day Moving Average | 5.35 |
| Relative Strength Index (RSI) | 50.33 |
| Average Volume (30 Days) | 2,394,892 |
Short Selling Information
The latest short interest is 6.13 million, so 8.70% of the outstanding shares have been sold short.
| Short Interest | 6.13M |
| Short Previous Month | 6.05M |
| Short % of Shares Out | 8.70% |
| Short % of Float | 10.62% |
| Short Ratio (days to cover) | 5.27 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -95.21M |
| Pretax Income | -125.32M |
| Net Income | -125.32M |
| EBITDA | -122.00M |
| EBIT | -124.88M |
| Earnings Per Share (EPS) | -$2.94 |
Balance Sheet
The company has $252.33 million in cash and $14.19 million in debt, giving a net cash position of $238.14 million or $3.38 per share.
| Cash & Cash Equivalents | 252.33M |
| Total Debt | 14.19M |
| Net Cash | 238.14M |
| Net Cash Per Share | $3.38 |
| Equity / Book Value | 196.06M |
| Book Value Per Share | 2.78 |
| Working Capital | 190.20M |
Cash Flow
| Operating Cash Flow | -67.63M |
| Capital Expenditures | n/a |
| Free Cash Flow | -67.63M |
| FCF Per Share | -$1.41 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MNMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.69% |
| Shareholder Yield | -25.69% |
| Earnings Yield | -20.20% |
| FCF Yield | -10.90% |
Analyst Forecast
The average price target for MNMD is $23.50, which is 167.05% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $23.50 |
| Price Target Difference | 167.05% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 29, 2022. It was a reverse split with a ratio of 1:15.
| Last Split Date | Aug 29, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |